Bio giant GSK counts on virtual network for new drug discovery
GlaxoSmithKline, Britain's biggest pharmaceutical company, is to launch a drug development initiative to take advantage of opportunities outside the company.
According to chief executive Jean-Pierre Garnier, "The virtual Cedd (Centre of Excellence for Drug Discovery) is about reaching beyond the walls to the world's laboratory". The virtual unit will consist of a small team of scientists focused on doing deals with biotechs, small and mid-sized pharmaceutical companies and academic institutions.......
Comments
Bioteams Books Reviews
Business networks are biological
Networks competing with networks is the future for supply chains. Harvard Professor Marco Iansiti in his book "The Keystone Advantage: What the New Dynamics of Business Ecosystems Mean for Strategy, Innovation and Sustainability" predicts that the future business competition will not be between companies or even supply chains but between networks.
Buy it now from:
Amazon.Com
Amazon.Co.UK













